{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:48:23Z","timestamp":1770749303887,"version":"3.50.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.clineuro.2005.03.013","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T15:02:16Z","timestamp":1117206136000},"page":"497-508","source":"Crossref","is-referenced-by-count":80,"title":["Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone"],"prefix":"10.1016","volume":"107","author":[{"given":"Peter Paul","family":"De Deyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira R.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Brodaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2005.03.013_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000064930","article-title":"Education, occupation, and prevalence of dementia: findings from the Conselice study","volume":"14","author":"Ravaglia","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.clineuro.2005.03.013_bib2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/gps.404","article-title":"The incidence of dementia in an Australian community population: the Sydney Older Persons Study","volume":"16","author":"Waite","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib3","first-page":"S10","article-title":"Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group","volume":"54","author":"Fratiglioni","year":"2000","journal-title":"Neurology"},{"issue":"Suppl. 21","key":"10.1016\/j.clineuro.2005.03.013_bib4","first-page":"3","article-title":"Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers","volume":"62","author":"Finkel","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2165\/00023210-199606040-00004","article-title":"Behavioural disorders in demented elderly patients","volume":"6","author":"Herrmann","year":"1996","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clineuro.2005.03.013_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/gps.382","article-title":"Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors","volume":"16","author":"Brodaty","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4088\/JCP.v62n0810","article-title":"A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments","volume":"62","author":"Ballard","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archpsyc.1997.01830150083012","article-title":"The course of psychopathologic features in mild to moderate Alzheimer disease","volume":"54","author":"Devanand","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/bjp.174.1.39","article-title":"Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease A longitudinal study","volume":"174","author":"Hope","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1176\/ajp.147.8.1049","article-title":"Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease","volume":"147","author":"Steele","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1532-5415.1990.tb02407.x","article-title":"A meta analysis of controlled trials of neuroleptic treatment of dementia","volume":"38","author":"Schneider","year":"1990","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clineuro.2005.03.013_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00002018-200023030-00002","article-title":"A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia","volume":"23","author":"Zaudig","year":"2000","journal-title":"Drug Safety"},{"key":"10.1016\/j.clineuro.2005.03.013_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00019442-199924710-00010","article-title":"Conventional versus newer antipsychotics in elderly patients","volume":"7","author":"Jeste","year":"1999","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1532-5415.1999.tb01595.x","article-title":"Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients","volume":"47","author":"Jeste","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clineuro.2005.03.013_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4088\/JCP.v64n0205","article-title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia","volume":"64","author":"Brodaty","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.03.013_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial","volume":"60","author":"Katz","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 21","key":"10.1016\/j.clineuro.2005.03.013_bib18","first-page":"19","article-title":"Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia","volume":"62","author":"De Deyn","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib19","first-page":"653","article-title":"Functional assessment staging (FAST)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.clineuro.2005.03.013_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"Suppl. 3:301\u2013308","key":"10.1016\/j.clineuro.2005.03.013_bib21","first-page":"351","article-title":"Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale","volume":"8","author":"Reisberg","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.clineuro.2005.03.013_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1532-5415.1986.tb04302.x","article-title":"Agitated behaviors in the elderly. I. A conceptual review","volume":"36","author":"Cohen-Mansfield","year":"1986","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clineuro.2005.03.013_bib23","first-page":"425","article-title":"Reliability and clinical concepts underlying global judgments in dementia: implications for clinical research","volume":"28","author":"Dahlke","year":"1992","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.clineuro.2005.03.013_bib24","first-page":"233","article-title":"The Extrapyramidal Symptom Rating Scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.clineuro.2005.03.013_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/appi.ajgp.12.5.499","article-title":"Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: secondary analysis of a double-blind, placebo-controlled trial","volume":"12","author":"Katz","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib26","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1176\/appi.ajp.157.7.1150","article-title":"Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone","volume":"47","author":"Jeste","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"Suppl. 10","key":"10.1016\/j.clineuro.2005.03.013_bib27","first-page":"55","article-title":"The relationship of pharmacology to side effects","volume":"58","author":"Casey","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clineuro.2005.03.013_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/00023210-200216110-00005","article-title":"Antipsychotic-induced venous thromboembolism: a review of the evidence","volume":"16","author":"Hagg","year":"2002","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.clineuro.2005.03.013_bib29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0149-2918(04)80097-3","article-title":"In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis","volume":"26","author":"De Clerck","year":"2004","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.clineuro.2005.03.013_bib30","first-page":"1269","article-title":"Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials","volume":"167","author":"Wooltorton","year":"2004","journal-title":"Can Med Assoc J"},{"issue":"Suppl. 2","key":"10.1016\/j.clineuro.2005.03.013_bib31","first-page":"261","article-title":"Risk of cerebrovascular adverse events, including mortality, with risperidone in elderly patients","volume":"PB-041","author":"Greenspan","year":"2003","journal-title":"Int Psychogeriatrics"},{"issue":"9","key":"10.1016\/j.clineuro.2005.03.013_bib32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1503\/cmaj.1040539","article-title":"Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials","volume":"170","author":"Wooltorton","year":"2004","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.clineuro.2005.03.013_bib33","unstructured":"Zyprexa (olanzapine) US prescribing information: http:\/\/pi.lilly.com\/us\/zyprexa-pi.pdf, as assessed on 23 April 2004. Eli Lilly and Company, 2004."},{"key":"10.1016\/j.clineuro.2005.03.013_bib34","unstructured":"Kozma C, Engelhart L, Long S, Greenspan A, Mahmoud R, Baser O. Absence of risperidone-related increased stroke risk among dementia patients. Poster Presented at the American Psychiatrist Association, 3 May, New York, NY, 2004."},{"issue":"6","key":"10.1016\/j.clineuro.2005.03.013_bib35","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/appi.ajp.161.6.1113","article-title":"Atypical antipsychotics and risk of cerebrovascular accidents","volume":"161","author":"Herrmann","year":"2004","journal-title":"Am J Psychiatry"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846705000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846705000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T07:26:23Z","timestamp":1548487583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846705000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0303846705000764"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2005.03.013","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}